News

Buy Windlas Biotech Ltd For Target Rs.289.4 - Choice Broking A pure play formulation CDMO company, at an attractive valuations With a revenue market share of 1.5%, Windlas Biotech Ltd. (WBL) is among the top-five contract development & manufacturing organization (CDMO) in the domestic pharma sector. It serves seven out of top-10 pharma formulation companies in India. The company focuses on therapeutic areas like cardiovascular, anti-diabetics, neurology, gastrointestinal, vitamins, minerals, nutrients etc. WBL operated in three verticals, namely...
Buy Windlas Biotech Ltd For Target Rs.289.4 - Choice Broking
Buy Windlas Biotech Ltd For Target Rs.289.4 - Choice Broking
Source: Choice Broking Pvt Ltd
7/07/2022 1:02:03 PM
Quote on should investors apply for the upcoming IPO after week listing of Windlas Biotech IPO by Mr. Yash Gupta, Angel Broking Ltd Below is quote on should investors apply for the upcoming IPO after week listing of Windlas biotech IPO by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd    After a week listing for Windlass Biotech, should investors apply for the upcoming IPOs? Windlas Biotech got listed at a 4.5% discount to its issue price of ₹460, despite the IPO getting a good response from investors and getting oversubscr...
Quote on should investors apply for the upcoming IPO after week listing of Windlas Biotech IPO by Mr. Yash Gupta, Angel Broking Ltd
Quote on should investors apply for the upcoming IPO after week listing of Windlas Biotech IPO by Mr. Yash Gupta, Angel Broking Ltd
Source: Angel Broking Ltd
18/08/2021 12:23:52 PM
Perspective on Listing of Devyani, Krsnaa, Windlas and Exxaro on the exchange today by Ms. Sneha Poddar, Motilal Oswal Financial Services Below is perspective on Listing of Devyani, Krsnaa, Windlas and Exxaro on the exchange today by Ms. Sneha Poddar, AVP – Research, Broking & Distribution, Motilal Oswal Financial Services Ltd. “Today four IPOs got listed - Devyani, Krsnaa, Windlas and Exxaro of which Devyani listed with stellar 56% premium while Krsnaa and Exxaro listed with tepid 7%/5% premium and Windlas at a discount. Currently midcaps and smallcaps are facing selling pressure and...
Perspective on Listing of Devyani, Krsnaa, Windlas and Exxaro on the exchange today by Ms. Sneha Poddar, Motilal Oswal Financial Services
Perspective on Listing of Devyani, Krsnaa, Windlas and Exxaro on the exchange today by Ms. Sneha Poddar, Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services Ltd
16/08/2021 2:44:22 PM
Quote on Windlas Biotech and Krsnaa diagnostics IPO expected listing gain by Mr. Yash Gupta, Angel Broking Ltd Below is quote on "Windlas Biotech and Krsnaa diagnostics IPO expected listing gain by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd    What to expect from both the pharmaceutical sector IPO listing and what’s the grey market premium signalling. Windlas biotech and Krsnaa diagnostic have received good response from investors and the IPO got oversubscribed by 22.4 times and 64 times respectively. Windlas biotech is engaged i...
Quote on Windlas Biotech and Krsnaa diagnostics IPO expected listing gain by Mr. Yash Gupta, Angel Broking Ltd
Quote on Windlas Biotech and Krsnaa diagnostics IPO expected listing gain by Mr. Yash Gupta, Angel Broking Ltd
Source: Angel Broking Ltd
11/08/2021 5:45:21 PM
Quote on Windlas biotech or Krisnaa diagnostic IPO by Mr. Yash Gupta, Angel Broking Ltd Below is quote on Windlas biotech or Krisnaa diagnostic IPO by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd  Which pharmaceutical sector IPO is better to apply for, Is it Windlas biotech or Krisnaa diagnostic? Both the IPO opens on 4th August and will close on 6th August 2021. Windlas biotech is engaged in the business of CDMO, domestic generic, and export business. CDMO accounts for 85% of the top line in FY2021 and CDMO business ...
Quote on Windlas biotech or Krisnaa diagnostic IPO by Mr. Yash Gupta, Angel Broking Ltd
Quote on Windlas biotech or Krisnaa diagnostic IPO by Mr. Yash Gupta, Angel Broking Ltd
Source: Angel Broking
5/08/2021 3:03:51 PM
Quote on Windlas Biotech Limited IPO Report by Mr. Yash Gupta, Angel Broking Ltd Below is quote on Windlas Biotech Limited IPO Report by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd    Windlas Biotech Ltd. The company was incorporated in 2001 based in Dehradun. The Company operating with 3 business verticals - 1. CDMO Products and services, 2. Domestic trade generics and Over-the-counter (OTC) market 3. Exports. The company currently owns and operates four manufacturing facilities located at Dehradun in Uttarakhan...
Quote on Windlas Biotech Limited IPO Report by Mr. Yash Gupta, Angel Broking Ltd
Quote on Windlas Biotech Limited IPO Report by Mr. Yash Gupta, Angel Broking Ltd
Source: Angel Broking Ltd
3/08/2021 4:17:24 PM
IPO Note - Windlas Biotech Ltd By Religare Broking About the Company Windlas Biotech Ltd is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry in India in terms of revenue. The company has over two decades of experience in manufacturing both solid and liquid pharmaceutical dosage forms and significant experience in providing specialized capabilities, including high potency, controlled substances and low solubility. It operates under three distinct str...
IPO Note - Windlas Biotech Ltd By Religare Broking
IPO Note - Windlas Biotech Ltd By Religare Broking
Source: Religare Broking Ltd
3/08/2021 11:34:10 AM
IPO Note - Windlas Biotech Ltd By Choice Broking Salient features of the IPO: * Pharmaceutical formulations contract developer and manufacturer Windlas Biotech Ltd. (WBL), is planning to raise up to Rs. 400cr through an IPO, which opens on 4th Aug. and closes on 6th Aug. 2021. The price band is Rs. 448 - 460 per share. * The issue is a combination of fresh and OFS. The company will not receive any proceeds from the OFS portion. Of the net proceeds from the fresh issue, Rs. 50cr will be utilized for capacity expansion and add...
IPO Note - Windlas Biotech Ltd By Choice Broking
IPO Note - Windlas Biotech Ltd By Choice Broking
Source: Choice Broking
30/07/2021 4:33:12 PM